KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $207,000 | -60.2% | 10,800 | -87.6% | 0.02% | -33.3% |
| Q2 2019 | $520,000 | -66.7% | 86,951 | -67.5% | 0.04% | -50.0% |
| Q1 2019 | $1,563,000 | -4.1% | 267,800 | +54.0% | 0.07% | -35.7% |
| Q4 2018 | $1,629,000 | +54.1% | 173,869 | +180.0% | 0.11% | +83.6% |
| Q3 2018 | $1,057,000 | -28.5% | 62,100 | +95.3% | 0.06% | -72.3% |
| Q2 2014 | $1,479,000 | +182.3% | 31,800 | +87.1% | 0.22% | +171.6% |
| Q1 2014 | $524,000 | -5.2% | 17,000 | -29.8% | 0.08% | -15.6% |
| Q4 2013 | $553,000 | – | 24,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |